Drug Development, Clinical Research, & Clinical Trial Services

A complete suite of capabilities across CRO and CDMO services—CRDMO

Your drug development journey can be accelerated and simplified from early development to clinical trials, through commercialization by our global, purpose-built, end-to-end CRO and CDMO expertise provided by PPD clinical research services, Patheon pharma services and Thermo Fisher Scientific.

Early Development and Pre-Clinical

Clinical Trials (Phase I–III)

Production, Commercialization, and Post-Approval

Being an integrated CRO and CDMO, a CRDMO provides you expertise and unparalleled resources for all phases of your drug development and manufacturing, from early development through clinical research and commercialization.

Our complete set of services can help take your molecule from research to market

We support your asset development with our combined CDMO and CRO—“CRDMO”—expertise. Thermo Fisher Scientific offers and end-to-end suite of drug development and clinical services spanning drug substance and drug product manufacturing for small molecule, large molecule and advanced therapies, clinical supply, clinical research, and commercialization.

Our unique fully end-to-end approach ensures shared accountability across the drug development process, enabling increased speed, simplicity, and scalability.

Click on any of the above 3 drug development phases to learn how your journey can be accelerated

Decades of experience bringing innovative therapies to market globally

We recognize the need to continually evolve and closely partner with our customers to support them throughout their journey of bringing innovative medicines to market.